Financial News
Latest News about Gilead Sciences Inc
Recent news which mentions Gilead Sciences Inc
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
From CNBC.com News
U.S. investors, Big Pharma race to find new medicines in China
February 13, 2025
From CNBC.com News
Salesforce picks board member Robin Washington to be its next finance and operating leader
February 05, 2025
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
November 07, 2024
From CNBC.com News
5 things to know before the stock market opens Friday
September 13, 2024
From CNBC.com News
Gilead's twice-yearly shot cut HIV infections by 96% in trial
September 12, 2024
From CNBC.com News
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuit
August 16, 2024
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
July 03, 2024
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
June 26, 2024
From CNBC.com News
5 things to know before the stock market opens Friday
June 21, 2024
From CNBC.com News
From CNBC.com News
From Business Journals
From Business Journals
Gilead stock falls after disappointing lung cancer study results
January 22, 2024
From CNBC.com News
Fraud in a bottle: How Big Pharma takes on criminals who make millions off counterfeit drugs
December 11, 2023
From CNBC.com News
Miami man pleads guilty to selling adulterated, misbranded HIV drugs across United States
September 26, 2023
From CNBC.com News
Stocks making the biggest moves midday: Kroger, DocuSign, Planet Labs, First Solar and more
September 08, 2023
Tickers
RH
From CNBC.com News
Stocks making the biggest moves before the bell: Kroger, DocuSign, Snowflake, Adobe and more
September 08, 2023
Tickers
RH
From CNBC.com News
Stocks making the biggest moves midday: AMC Entertainment, Mattel, Chevron, Spotify and more
July 24, 2023
From CNBC.com News
Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
June 29, 2023
From CNBC.com News
From CNBC.com News
Gilead Sciences didn't violate government patents on HIV prevention treatment, jury finds
May 09, 2023
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
From CNBC.com News
Under-the-radar trend shows tech investors remain loyal despite major losses this year
October 30, 2022
From CNBC.com News
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
